Umbilical Cord Milking for Neonates With Hypoxic Ischemic Encephalopathy
- Conditions
- Umbilical Cord MilkingHypoxic Ischemic Encephalopathy
- Interventions
- Procedure: Umbilical Cord Milking
- Registration Number
- NCT02287077
- Lead Sponsor
- Thomas Jefferson University
- Brief Summary
The objective of this pilot study is to investigate the feasibility of performing umbilical cord milking in neonates who are depressed at birth.
- Detailed Description
Hypoxic-ischemic encephalopathy (HIE) is a brain injury in neonates due to inadequate blood flow and oxygen delivery to the neonatal brain. Umbilical cord milking can potentially improve brain injury in neonates with HIE. The objective of this study is to investigate the feasibility of performing umbilical cord milking in neonates who are depressed at birth. The investigators hypothesized that umbilical cord milking is feasible and safe in neonates who are depressed at birth. The investigators also hypothesized that umbilical cord milking will increase stem cells in neonatal blood circulation and improve short term outcomes in neonates with moderate and severe HIE.
Recruitment & Eligibility
- Status
- COMPLETED
- Sex
- All
- Target Recruitment
- 101
- Term and near term neonates (35 weeks and more)
- Depressed at birth
- Congenital malformation of central nervous system
- Chromosomal abnormalities
- Major congenital malformations
Study & Design
- Study Type
- INTERVENTIONAL
- Study Design
- PARALLEL
- Arm && Interventions
Group Intervention Description Umbilical cord milking Umbilical Cord Milking At birth, neonate will be held below the level of placenta and umbilical cord will be milked 3 times before clamping the cord.
- Primary Outcome Measures
Name Time Method The number of depressed neonates in whom umbilical cord milking was performed. Participants will be followed for the duration of hospital stay, an expected average of 5 days The number of neonates who are depressed at birth will be determined and the percentage of depressed neonates in whom UCM performed will be calculated. The investigators expect that more than 80% of neonates who qualify will receive UCM. The investigators will aslo compare resuscitation efforts (use of positive pressure ventilation, intubation, chest compression, medication and fluid boluses) and short term outcomes of resuscitation (5 minutes apgar, severity of HIE, blood gas at 1 hour) in neonates with and without UCM.
- Secondary Outcome Measures
Name Time Method The effect of umbilical cord milking on stem and progenitor cells in peripheral blood of neonates. 24 hours Evaluate stem and progenitor cell count in peripheral blood of neonates with UCM and compare them with the control group (no UCM).
The effect of umbilical cord milking on neurotrophic factors in peripheral blood of neonates. 24 hours Compare levels of neurotrophic factors in peripheral blood of neonates with and without UCM.
The effect of umbilical cord milking on monocytes and lymphocytes in peripheral blood of neonates. 24 hours Evaluate absolute monocyte and lymphocyte count in peripheral blood of neonates with UCM and compare them with the control group (no UCM).
Survival and short term outcomes in neonates with moderate and severe HIE Participants will be followed for the duration of hospital stay, an expected average of 5 days In infants with moderate or severe HIE, compare survival, neurological examination at discharge, and neuro-imaging studies in infants with and without UCM.
Trial Locations
- Locations (1)
Lata Mangeshkar Hospital and NKP Salve Institute of Medical Sciences
🇮🇳Nagpur, MS, India